Acme United (ACU) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Achieved record net sales of $194.5 million and record EBITDA of $20 million for 2024, with net income rising 23% year-over-year to $10 million.
Sold Cuda and Camillus hunting and fishing business in November 2023 for $19.8 million, using proceeds to reduce debt and support growth.
Adjusted net revenues (excluding divested businesses) increased 6% in 2024.
Elite First Aid acquisition in May 2024 for $6.1 million was fully integrated, supporting growth in first responder kits.
Productivity improvements and cost reductions offset lost contributions from divested businesses.
Financial highlights
Fourth quarter net sales were $45.9 million, up 10% year-over-year; full-year net sales rose 2% to $194.5 million.
Gross margin for 2024 was 39.3%, up from 37.7% in 2023, driven by productivity improvements.
SG&A expenses for 2024 were $62 million (32% of sales), up from $59 million (31% of sales) in 2023, mainly due to inflation and wage increases.
Interest expense declined to $1.9 million from $3 million due to lower average debt.
EPS for 2024 was $2.45, up 10% from $2.23 in 2023.
Outlook and guidance
Management expects further growth in 2025, leveraging strong liquidity, a solid customer base, and the Elite First Aid acquisition.
SG&A expected to remain between 31% and 32% of sales going forward.
Plans to expand distribution and sales of first responder kits and pursue additional acquisitions.
Latest events from Acme United
- All proposals, including board elections and stock plan amendments, were approved by majority vote.ACU
AGM 202628 Apr 2026 - Sales up 14% but net income down 40% as tariffs and SG&A offset acquisition gains.ACU
Q1 202624 Apr 2026 - Shareholders will vote on director elections, stock option plan expansion, executive pay, and auditor ratification.ACU
Proxy filing27 Mar 2026 - Record 2025 results and Q4 growth, with acquisitions and investments fueling future expansion.ACU
Q4 202527 Feb 2026 - Q2 net income up 29% with margin gains and Elite First Aid acquisition completed.ACU
Q2 20243 Feb 2026 - Q3 net sales fell 4% but net income rose 3% as Europe and product lines outperformed.ACU
Q3 202419 Jan 2026 - Record sales, product innovation, and supply chain shifts drive growth and margin expansion.ACU
17th Annual LD Micro Main Event Conference18 Jan 2026 - Revenue growth, innovation, and acquisitions position the firm for $300M in sales by 2027.ACU
2024 Southwest IDEAS Conference12 Jan 2026 - Annual meeting to vote on directors, executive pay, auditor, and say-on-pay frequency.ACU
Proxy Filing1 Dec 2025